Cel
RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk groups. RESCEU brings together academia, national public health agencies and EFPIA with proven expertise and a strong track record in RSV research. The academic partners are leaders in RSV epidemiology, clinical RSV research, health economics, and vaccinology; and key opinion leaders with advisory roles in European and national public health bodies, health technology agencies and vaccine advisory groups. EFPIA participants (AZ, GSK, JPNV, Novavax, Pfizer, and SP) have active clinical research programmes to develop lead candidates for treatment and prevention of RSV in infants, adults and the elderly. As part of RESCEU, EFPIA participants will contribute expertise in a wide range of fields including infectious disease, clinical medicine, immunology, epidemiology, biostatistics, biomarker development, global health, and health economics. RESCEU’s aim is to develop robust evidence on RSV disease burden and economic impact; create a sustainable Europe-wide multidisciplinary, multi-stakeholder community from academia, public health, scientific societies, patient organisations, regulatory agencies and industry; and provide infrastructure to perform future pivotal trials for RSV vaccines and therapeutics. RESCEU aims to provide sustainable longer term impact on RSV disease burden and thus make a significant contribution to improved health and wellbeing in Europe.
The project will comprise 6 work packages. WP 1-3 will identify and marshal data from large-scale systematic reviews of epidemiological and cost studies, disease registries, linked routine (national) healthcare and claims datasets and will establish a framework for and assemble data from RSV surveillance in Europe to estimate RSV disease burden on health services and inform economic models.
Dziedzina nauki
Słowa kluczowe
Program(-y)
Zaproszenie do składania wniosków
H2020-JTI-IMI2-2015-06-two-stage
Zobacz inne projekty w ramach tego zaproszeniaSystem finansowania
RIA - Research and Innovation actionKoordynator
EH8 9YL Edinburgh
Zjednoczone Królestwo
Zobacz na mapie
Uczestnicy (18)
2000 Antwerpen
Zobacz na mapie
3584 CX Utrecht
Zobacz na mapie
OX1 2JD Oxford
Zobacz na mapie
Zakończenie uczestnictwa
28006 Madrid
Zobacz na mapie
Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.
SW7 2AZ LONDON
Zobacz na mapie
15703 Santiago De Compostela
Zobacz na mapie
20520 Turku
Zobacz na mapie
3721 MA Bilthoven
Zobacz na mapie
2300 Kobenhavn S
Zobacz na mapie
9713 GZ Groningen
Zobacz na mapie
35127 Padova
Zobacz na mapie
151 85 Sodertaelje
Zobacz na mapie
CT13 9NJ Sandwich
Zobacz na mapie
1330 Rixensart
Zobacz na mapie
69007 Lyon
Zobacz na mapie
2340 Beerse
Zobacz na mapie
20878 Gaithersburg
Zobacz na mapie
08007 Barcelona
Zobacz na mapie
Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.